MedTrace Logo

Effect of Specific ACL Injury Prevention Training in Female Handball Players

NCT05955599 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-07-21

No results posted yet for this study

Summary

The anterior Cruciate Ligament (ACL) injuries rates in female handball are high, particularly among adolescents. Therefore, the primary purpose of this randomized control trial is to explore the effects of an 8-week ACL injury prevention program on muscle activation of the medial hamstring muscles during sidecutting in female handball players.

Secondary aims are to evaluate if training effects are age-related (pre-adolescent: 11-13 year old vs. adults: ≥18 years old). The age-related comparisons Include:

1. Medial hamstring muscles activation during sidecutting;
2. Well-known biomechanical ACL injury-risk factors during high risk movements, such as cutting and landing tasks;
3. Cortical and muscular activity and functional connectivity patterns during controlled knee movements;
4. Visuomotor skill learning during a simple task involving the hamstring muscles.

Conditions

  • ACL Injury Prevention

Interventions

OTHER

ACL Injury Prevention Training

Supervised ACL injury prevention training twice a week (2 x 15 minutes) over an 8-week period.

OTHER

Control - Shoulder Injury Prevention Training

Supervised shoulder injury prevention training twice a week (2 x 15 minutes) over an 8-week period.

Sponsors & Collaborators

  • University College Copenhagen

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Team Denmark

    collaborator OTHER

  • Copenhagen University Hospital, Hvidovre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-02-28
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05955599 on ClinicalTrials.gov